Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Community-centered training to reduce pregnancy-related harm and deaths

Official title: Multilevel Community-centered Intervention to Reduce Pregnancy Related and Associated Morbidity and Mortality (PRAMM) Disparities in Non-Hispanic Black and Hispanic Medicaid-insured Individuals

Run by Michigan State University · NCT07025057 · Data updated 2026-11-12

This project will train health care providers who care for pregnant and postpartum women in Wayne, Kent, and Genesee counties, Michigan to try improved communication and referral practices aimed at reducing pregnancy-related harm for non-Hispanic Black women.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment480 (estimated)
SponsorMichigan State University
Academic / other
Locations1 site (Grand Rapids, Michigan)
StatusRecruiting
StartedFebruary 3, 2025
Main results expectedAugust 1, 2029
Study endsAugust 15, 2030
Registry record updatedJuly 7, 2026
Trial IDNCT07025057 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are health care providers who deliver care to pregnant and postpartum women in Wayne, Kent, or Genesee Counties, Michigan, particularly those serving non-Hispanic Black patients.

Probably not a fit

Patients who do not receive care from participating providers, live outside the target counties, or whose outcomes are driven by factors not addressed by provider communication and referral practices may not experience direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a provider- and practice-level intervention that delivers experiential trainings on communication, cultural relevance, and community referral pathways (including community health workers and home visiting) to clinicians caring for pregnant and postpartum women. Trainings combine self-learning, didactics, reflection, discussion, and actionable planning to tailor practices to local settings and to better hear, respect, and meet the needs of perinatal non-Hispanic Black women. The study measures pre- and post-training provider knowledge, confidence, and reported behavior changes via surveys. Implementation occurs in clinical and community settings serving Wayne, Kent, and Genesee Counties, Michigan.

Why it matters

Potential benefit: If successful, patients—especially perinatal non-Hispanic Black women—could experience clearer communication, more culturally relevant care, stronger connections to community supports, and a reduced risk of pregnancy-related complications and deaths.

How similar studies have gone: Similar provider communication and community-referral programs have improved provider knowledge and patient experience in prior work, but evidence that they directly reduce maternal morbidity and mortality disparities is limited and mixed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Providing care to pregnant and postpartum women in Wayne, Kent, and Genesee Counties in MI

Exclusion Criteria:

* None

Where it's running

  • Strong Beginings
    Grand Rapids, Michigan, United States
    Recruiting

Study contacts

  • Principal investigator: Cristian Meghea, PhD — Michigan State University
  • Study coordinator: Jennifer Raffo, MA
  • Email: overfiel@msu.edu
  • Phone: 12487161043

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.